242 related articles for article (PubMed ID: 26529488)
1. Visuomotor control in patients with Parkinson's disease.
Chen J; Ho SL; Lee TM; Chang RS; Pang SY; Li L
Neuropsychologia; 2016 Jan; 80():102-114. PubMed ID: 26529488
[TBL] [Abstract][Full Text] [Related]
2. Response to sensory uncertainty in Parkinson's disease: a marker of cerebellar dysfunction?
Stevenson JK; Oishi MM; Farajian S; Cretu E; Ty E; McKeown MJ
Eur J Neurosci; 2011 Jan; 33(2):298-305. PubMed ID: 21155903
[TBL] [Abstract][Full Text] [Related]
3. Joint principles of motor and cognitive dysfunction in Parkinson's disease.
Schönberger AR; Barbe MT; Hagelweide K; Kühn AB; Fink GR; Schubotz RI
Neuropsychologia; 2013 Jul; 51(8):1417-25. PubMed ID: 23628367
[TBL] [Abstract][Full Text] [Related]
4. Impact of Parkinson's disease and dopaminergic medication on adaptation to explicit and implicit visuomotor perturbations.
Mongeon D; Blanchet P; Messier J
Brain Cogn; 2013 Mar; 81(2):271-82. PubMed ID: 23313834
[TBL] [Abstract][Full Text] [Related]
5. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing.
Mongeon D; Blanchet P; Messier J
Neuroscience; 2009 Jan; 158(2):426-40. PubMed ID: 18996173
[TBL] [Abstract][Full Text] [Related]
6. l-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson's disease.
Kwak Y; Müller ML; Bohnen NI; Dayalu P; Seidler RD
Behav Brain Res; 2012 Apr; 230(1):116-24. PubMed ID: 22343069
[TBL] [Abstract][Full Text] [Related]
7. Drug treatment and familiar music aids an attention shift from vision to somatosensation in Parkinson's disease on the reach-to-eat task.
Sacrey LA; Travis SG; Whishaw IQ
Behav Brain Res; 2011 Mar; 217(2):391-8. PubMed ID: 21073905
[TBL] [Abstract][Full Text] [Related]
8. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
[TBL] [Abstract][Full Text] [Related]
9. Virtually-induced threat in Parkinson's: Dopaminergic interactions between anxiety and sensory-perceptual processing while walking.
Ehgoetz Martens KA; Ellard CG; Almeida QJ
Neuropsychologia; 2015 Dec; 79(Pt B):322-31. PubMed ID: 26004056
[TBL] [Abstract][Full Text] [Related]
10. Behavioral inhibition errors in Parkinson's disease tested using an antisaccade and antitapping task.
de Boer C; Pel JJ; van den Dorpel JJ; Boon AJ; van der Steen J
J Parkinsons Dis; 2014; 4(4):599-608. PubMed ID: 25015545
[TBL] [Abstract][Full Text] [Related]
11. Action naming in Parkinson's disease patients on/off dopamine.
Herrera E; Cuetos F
Neurosci Lett; 2012 Apr; 513(2):219-22. PubMed ID: 22387157
[TBL] [Abstract][Full Text] [Related]
12. Audiovisual Processing is Abnormal in Parkinson's Disease and Correlates with Freezing of Gait and Disease Duration.
Fearon C; Butler JS; Newman L; Lynch T; Reilly RB
J Parkinsons Dis; 2015; 5(4):925-36. PubMed ID: 26485427
[TBL] [Abstract][Full Text] [Related]
13. Failed suppression of direct visuomotor activation in Parkinson's disease.
Praamstra P; Plat FM
J Cogn Neurosci; 2001 Jan; 13(1):31-43. PubMed ID: 11224907
[TBL] [Abstract][Full Text] [Related]
14. Levodopa slows prosaccades and improves antisaccades: an eye movement study in Parkinson's disease.
Hood AJ; Amador SC; Cain AE; Briand KA; Al-Refai AH; Schiess MC; Sereno AB
J Neurol Neurosurg Psychiatry; 2007 Jun; 78(6):565-70. PubMed ID: 17178817
[TBL] [Abstract][Full Text] [Related]
15. Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson's disease.
Vaillancourt DE; Prodoehl J; Verhagen Metman L; Bakay RA; Corcos DM
Brain; 2004 Mar; 127(Pt 3):491-504. PubMed ID: 14662520
[TBL] [Abstract][Full Text] [Related]
16. Disruption of pupil size modulation correlates with voluntary motor preparation deficits in Parkinson's disease.
Wang CA; McInnis H; Brien DC; Pari G; Munoz DP
Neuropsychologia; 2016 Jan; 80():176-184. PubMed ID: 26631540
[TBL] [Abstract][Full Text] [Related]
17. Visuomotor adaptation in Parkinson's disease: effects of perturbation type and medication state.
Semrau JA; Perlmutter JS; Thoroughman KA
J Neurophysiol; 2014 Jun; 111(12):2675-87. PubMed ID: 24694937
[TBL] [Abstract][Full Text] [Related]
18. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease.
Jones CR; Malone TJ; Dirnberger G; Edwards M; Jahanshahi M
Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374
[TBL] [Abstract][Full Text] [Related]
19. Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.
Martinu K; Degroot C; Madjar C; Strafella AP; Monchi O
Eur J Neurosci; 2012 Feb; 35(4):572-83. PubMed ID: 22304628
[TBL] [Abstract][Full Text] [Related]
20. Effects of aging, Parkinson's disease, and dopaminergic medication on response selection and control.
Willemssen R; Falkenstein M; Schwarz M; Müller T; Beste C
Neurobiol Aging; 2011 Feb; 32(2):327-35. PubMed ID: 19269061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
